针对阿尔茨海默氏症和帕金森病的数字治疗方法:当前趋势和未来前景
Yoo Joo Jeong1,2,3, Hyun-Ju Lee1,2, Jun-Su Kim2
1Department of Neural Development and Disease, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea.
Medicinal research reviews
|August 1, 2025
概括
数字疗法 (DTx) 显示出治疗神经退行性疾病 (NDD) 的希望,例如阿尔茨海默氏症和帕金森病,通过准认知和运动功能. 需要进一步的研究来克服DTx的挑战,并释放它们的全部治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 数字健康数字健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 和帕金森病 (PD) 是主要的神经退行性疾病 (NDD),其特点是蛋白质聚合和功能衰退.
- 目前针对AD和PD的药物治疗只能缓解症状,不能解决潜在的病理问题.
研究的目的:
- 审查当前的阿尔茨海默病和PD治疗格局.
- 检查NDD的数字治疗 (DTx) 的发展和特征.
- 讨论DTx在治疗AD和PD方面的挑战和未来方向.
主要方法:
- 对阿尔茨海默病和PD的治疗开发的文献综述.
- 对针对NDDs认知和运动功能的现有数字治疗方法 (DTx) 的分析.
- 讨论与DTx实施相关的局限性和挑战.
主要成果:
- 大多数AD和PD的DTx都专注于分别增强认知或运动功能.
- 现有的AD和PD药物有效性有限,主要是减缓疾病的进展.
- DTx提出了一种新的NDD管理方法,补充了传统疗法.
结论:
- 数字疗法 (DTx) 作为神经退行性疾病 (NDD) 的补充治疗方式具有显著的潜力.
- 解决DTx的局限性和挑战对于其成功融入临床实践至关重要.
- 未来的研究应该专注于优化DTx开发和应用,以改善AD和PD患者的治疗结果.
相关概念视频
01:15Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
01:24Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
01:26Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
01:28Drug Therapy
100
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
100
01:30Dementia
166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
166